Exclusion Criteria Used in Antidepressant Efficacy Trials-Reference-Cited by-同舟云学术

Exclusion Criteria Used in Antidepressant Efficacy Trials

Published:2004-02 Issue:2 Volume:192 Page:87-94
ISSN:0022-3018
Container-title:Journal of Nervous & Mental Disease
language:en
Short-container-title:

Author:

Zimmerman Mark,Chelminski Iwona,Posternak Michael A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health

Reference73 articles.

1. Once- versus twice-daily venlafaxine therapy in major depression: A randomized, double-blind study;Amsterdam;J Clin Psychiatry,1998

2. Dexamethasone for the treatment of depression: A randomized, placebo-controlled, double-blind trial;Arana;Am J Psychiatry,1995

3. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression;Baldwin;J Clin Psychiatry,1996

4. Methods to improve diagnostic accuracy in a community mental health setting;Basco;Am J Psychiatry,2000

5. Mirtazapine compared with paroxetine in major depression;Benkert;J Clin Psychiatry,2000

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eligibility of emergency psychiatry patients for clinical trials studying depression;Journal of Affective Disorders;2023-12

2. Borrowing strength from clinical trials in analysing longitudinal data from a treated cohort: investigating the effectiveness of acetylcholinesterase inhibitors in the management of dementia;International Journal of Epidemiology;2022-10-11

3. Are study populations in trials of antidepressants and psychotherapy comparable? A retrospective case study of two parallel running trials for multi- organ functional somatic disorder;Psychiatry Research;2022-05

4. Comprehending the potential of metallic, lipid, and polymer-based nanocarriers for treatment and management of depression;Neurochemistry International;2022-02

5. A systematic review of the characteristics of adolescents with major depressive disorder in randomised controlled treatment trials;The European Journal of Psychiatry;2022-01